SOX2 and small cell lung carcinoma: Prospective studies in SCLC patients have indicated that the presence of SOX2 antibody on its own is not related to a distinct pure neurological phenotype, suggesting that SOX antibodies may be of most use in predicting the presence of an underlying SCLC with high specificity (Maddison et al., 2010; Chapman et al., 2011).